(4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid

C52H55N7O11 — CID 121317922

IUPAC(4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid
SMILESCOc1ccc(C2=CN3C(=O)c4cc(OC)c(OCCCOc5cc6c(cc5OC)C(=O)N5C=C(c7ccc(NC(=O)[C@H](CCC(=O)O)NC(=O)C(N)C(C)C)cc7)C[C@H]5C=N6)cc4N=C[C@@H]3C2)cc1
InChIInChI=1S/C52H55N7O11/c1-29(2)48(53)50(63)57-40(15-16-47(60)61)49(62)56-34-11-7-30(8-12-34)32-19-35-25-54-41-23-45(43(67-4)21-38(41)51(64)58(35)27-32)69-17-6-18-70-46-24-42-39(22-44(46)68-5)52(65)59-28-33(20-36(59)26-55-42)31-9-13-37(66-3)14-10-31/h7-14,21-29,35-36,40,48H,6,15-20,53H2,1-5H3,(H,56,62)(H,57,63)(H,60,61)/t35-,36-,40-,48?/m0/s1
InChIKeyBHRLGXNTPXJQEC-NRMJHNQXSA-N
MW954.05 g/mol
LogP6.77
Rot. Bonds19

About (4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid

(4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid (PubChem CID 121317922) has the molecular formula C52H55N7O11 and a molecular weight of 954.05 g/mol. Its IUPAC name is (4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid.

Molecular Properties

Compound Name(4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid
PubChem CID121317922
Molecular FormulaC52H55N7O11
Molecular Weight954.05 g/mol
Exact Mass953.40
IUPAC Name(4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid
SMILESCOc1ccc(C2=CN3C(=O)c4cc(OC)c(OCCCOc5cc6c(cc5OC)C(=O)N5C=C(c7ccc(NC(=O)[C@H](CCC(=O)O)NC(=O)C(N)C(C)C)cc7)C[C@H]5C=N6)cc4N=C[C@@H]3C2)cc1
InChIInChI=1S/C52H55N7O11/c1-29(2)48(53)50(63)57-40(15-16-47(60)61)49(62)56-34-11-7-30(8-12-34)32-19-35-25-54-41-23-45(43(67-4)21-38(41)51(64)58(35)27-32)69-17-6-18-70-46-24-42-39(22-44(46)68-5)52(65)59-28-33(20-36(59)26-55-42)31-9-13-37(66-3)14-10-31/h7-14,21-29,35-36,40,48H,6,15-20,53H2,1-5H3,(H,56,62)(H,57,63)(H,60,61)/t35-,36-,40-,48?/m0/s1
InChIKeyBHRLGXNTPXJQEC-NRMJHNQXSA-N
XLogP6.77
TPSA233.01 Ų
H-Bond Donors4
H-Bond Acceptors13
Rotatable Bonds19
Heavy Atoms70
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500954.05
LogP ≤ 56.77
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid?
The IUPAC name of (4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid (CID 121317922) is (4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid.
What is the SMILES notation for (4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid?
The canonical SMILES for (4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid is COc1ccc(C2=CN3C(=O)c4cc(OC)c(OCCCOc5cc6c(cc5OC)C(=O)N5C=C(c7ccc(NC(=O)[C@H](CCC(=O)O)NC(=O)C(N)C(C)C)cc7)C[C@H]5C=N6)cc4N=C[C@@H]3C2)cc1.
What is the InChIKey of (4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid?
The InChIKey is BHRLGXNTPXJQEC-NRMJHNQXSA-N. The full InChI is InChI=1S/C52H55N7O11/c1-29(2)48(53)50(63)57-40(15-16-47(60)61)49(62)56-34-11-7-30(8-12-34)32-19-35-25-54-41-23-45(43(67-4)21-38(41)51(64)58(35)27-32)69-17-6-18-70-46-24-42-39(22-44(46)68-5)52(65)59-28-33(20-36(59)26-55-42)31-9-13-37(66-3)14-10-31/h7-14,21-29,35-36,40,48H,6,15-20,53H2,1-5H3,(H,56,62)(H,57,63)(H,60,61)/t35-,36-,40-,48?/m0/s1.
What are the key properties of (4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid?
(4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid has a molecular weight of 954.05 g/mol, XLogP of 6.77, 19 rotatable bonds, 4 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (4S)-5-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-4-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid is sourced from PubChem (CID 121317922), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).